Vireo Growth VREOF
OTC VREOF
$10.97 -0.01 (-0.09%)
At close: Aug 19, 2026 · 3:35 PM UTC

Vireo Growth (VREOF) Liabilities from Discontinued Operations (2020 - 2025)

Vireo Growth (VREOF) posted Liabilities from Discontinued Operations of 89334872.0 for Q3 2025, little changed sequentially from 89379390.0 in Q2 2025, and up 1.02% YoY from 88437021.0 in Q3 2024.

Vireo Growth (VREOF) Liabilities from Discontinued Operations (2020 - 2025) Analysis & Trends

Vireo Growth has reported Liabilities from Discontinued Operations for 6 years, with the latest figure at 89334872.0 in Q3 2025.

  • Quarterly Liabilities from Discontinued Operations rose 1.02% year-over-year to 89334872.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 89334872.0 (up 1.02% YoY) and the FY2024 annual result came in at 89387203.0, up 1.2% from the prior year.
  • Liabilities from Discontinued Operations was little changed at 89334872.0 in Q3 2025 per VREOF's latest filing, from 89379390.0 in the prior quarter.
  • Over five years, Liabilities from Discontinued Operations peaked at 89387203.0 in Q4 2024 and troughed at 116803.0 in Q3 2021.
  • A 5-year average of 58887381.31 and a median of 81925789.0 in 2023 frame the typical range for Liabilities from Discontinued Operations.
  • The sharpest annual moves came in 2023 and 2025: Liabilities from Discontinued Operations soared 6592.16% in 2023, then grew 1.02% in 2025.
  • Over 5 years, Liabilities from Discontinued Operations stood at 116803.0 in 2021, then jumped by 1029.98% to 1319847.0 in 2022, then jumped by 6592.16% to 88326323.0 in 2023, then gained by 1.2% to 89387203.0 in 2024, then dropped by 0.06% to 89334872.0 in 2025.
  • According to Business Quant data, Liabilities from Discontinued Operations over the past three periods registered 89334872.0, 89379390.0, and 89351157.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.07 Bn 43.10 Bn -
2 Teva Pharmaceutical Industries 43.41 Bn 39.75 Bn 2.15 Bn
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.77 Bn 22.97 Bn 5.10 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn
8 Elanco Animal Health 11.93 Bn 11.40 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn -
10 Vireo Growth 491.44 Mn 349.14 Mn 95.30 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 89.33 Mn
Sep 30, 2025 89.33 Mn
Jun 30, 2025 89.38 Mn
Jun 30, 2025 89.38 Mn
Mar 31, 2025 89.35 Mn
Mar 31, 2025 89.35 Mn
Dec 31, 2024 89.39 Mn
Dec 31, 2024 89.39 Mn
Sep 30, 2024 88.44 Mn
Sep 30, 2024 88.44 Mn
Jun 30, 2024 88.41 Mn
Jun 30, 2024 88.41 Mn
Mar 31, 2024 88.37 Mn
Mar 31, 2024 88.37 Mn
Dec 31, 2023 88.33 Mn
Dec 31, 2023 88.33 Mn
Sep 30, 2023 75.44 Mn
Sep 30, 2023 75.44 Mn
Jun 30, 2023 75.15 Mn
Jun 30, 2023 75.15 Mn